Related Experiment Video
Updated: Sep 13, 2025
14:53
A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis
Published on: September 10, 2014
17.3K
Electrochemical Impedance Spectroscopy-Based Biosensors for Label-Free Detection of Pathogens
Huaiwei Zhang1, Zhuang Sun2, Kaiqiang Sun2
1College of Materials and Environmental Engineering, Hangzhou Dianzi University, Hangzhou 310018, China.
Biosensors
|July 25, 2025
Summary
Electrochemical impedance spectroscopy (EIS) biosensors offer rapid, sensitive, label-free detection of infectious diseases at the point of care. This review details EIS sensor design, pathogen detection applications, and future challenges for diagnostics.
Area of Science:
- Biosensor Technology
- Infectious Disease Diagnostics
- Electrochemical Methods
Background:
- Rising infectious disease threats demand advanced diagnostic tools.
- Electrochemical impedance spectroscopy (EIS) is a promising label-free detection technique.
- EIS offers sensitivity, non-invasiveness, and adaptability for pathogen identification.
Purpose of the Study:
- To provide a comprehensive review of EIS-based biosensors for pathogen detection.
- To analyze critical components, signal generation mechanisms, and performance metrics.
- To explore applications, challenges, and future directions in EIS biosensor development.
Main Methods:
- Review of EIS biosensor design principles, including biorecognition elements and electrode materials.
- Analysis of nanomaterial integration and surface immobilization strategies.
- Examination of signal generation in Faradaic and non-Faradaic modes for performance evaluation.
Main Results:
- EIS biosensors demonstrate potential for detecting bacterial, viral, fungal, and parasitic pathogens.
- Case studies show successful detection in complex matrices like blood, saliva, food, and water.
- Integration with microfluidics and point-of-care systems is advancing real-world deployment.
Conclusions:
- EIS biosensors are evolving with multiplexed detection and novel nanomaterials.
- Key challenges include non-specific binding, matrix effects, and stability.
- Further development is crucial for robust, scalable EIS biosensors in healthcare and monitoring.
